Toll-like receptor 4-mediated cAMP production up-regulates B-cell activating factor expression in Raw264.7 macrophages

Experimental Cell Research

Volumn 317, Issue 17, 2011, Pages 2447-2455

  Moon, Eun Yi ^a   Lee, Yu Sun ^a   Choi, Wahn Soo ^b   Lee, Mi Hee ^a  

^a Sejong University   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

CAMP; CPT; CREB; Epac; MBAFF; PKA; Rap1

Indexed keywords

8 (4 CHLOROPHENYLTHIO) CYCLIC AMP; B CELL ACTIVATING FACTOR; BETA ACTIN; BUCLADESINE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GUANINE NUCLEOTIDE EXCHANGE FACTOR; LIPOPOLYSACCHARIDE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; RAP1 PROTEIN; S6 KINASE; SERINE; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 4; TUBULIN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BONE MARROW; CONTROLLED STUDY; ENZYME ACTIVATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

RICE STRIPE VIRUS;

EID: 80052634953     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.07.003     Document Type: Article

References (37)

1. Mackay F., Schneider P., Rennert P., Browning J. BAFF AND APRIL: a tutorial on B cell survival. Annu. Rev. Immunol. 2003, 21:231-264.
2. Mak T.W., Yeh W.C. Signaling for survival and apoptosis in the immune system. Arthritis Res. 2002, 4(Suppl. 3):S243-S252.
3. Mackay F., Woodcock S.A., Lawton P., Ambrose C., Baetscher M., Schneider P., Tschopp J., Browning J.L. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 1999, 190:1697-1710.
4. Schneider P., MacKay F., Steiner V., Hofmann K., Bodmer J.L., Holler N., Ambrose C., Lawton P., Bixler S., Acha-Orbea H., Valmori D., Romero P., Werner-Favre C., Zubler R.H., Browning J.L., Tschopp J. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 1999, 189:1747-1756.
5. Fu L., Lin-Lee Y.C., Pham L.V., Tamayo A., Yoshimura L., Ford R.J. Constitutive NF-kappaB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas. Blood 2006, 107:4540-4548.
6. He B., Chadburn A., Jou E., Schattner E.J., Knowles D.M., Cerutti A. Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL. J. Immunol. 2004, 172:3268-3279.
7. Tai Y.T., Li X.F., Breitkreutz I., Song W., Neri P., Catley L., Podar K., Hideshima T., Chauhan D., Raje N., Schlossman R., Richardson P., Munshi N.C., Anderson K.C. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment. Cancer Res. 2006, 66:6675-6682.
8. Moon E.Y., Lee J.H., Oh S.Y., Ryu S.K., Kim H.M., Kwak H.S., Yoon W.K. Reactive oxygen species augment B-cell-activating factor expression. Free Radic. Biol. Med. 2006, 40:2103-2111.
9. Kim Y.H., Choi B.H., Cheon H.G., Do M.S. B cell activation factor (BAFF) is a novel adipokine that links obesity and inflammation. Exp. Mol. Med. 2009, 41:208-216.
10. Moon E.Y., Park H. B cell activating factor (BAFF) gene promoter activity depends upon co-activator, p300. Immunobiology 2007, 212:637-645.
11. Kim H.A., Jeon S.H., Seo G.Y., Park J.B., Kim P.H. TGF-beta1 and IFN-gamma stimulate mouse macrophages to express BAFF via different signaling pathways. J. Leukoc. Biol. 2008, 83:1431-1439.
12. Caggiano A.O., Kraig R.P. Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1beta production. J. Neurochem. 1999, 72:565-575.
13. Moon E.Y., Oh S.Y., Han G.H., Lee C.S., Park S.K. Epac1-mediated Rap1 activation is not required for the production of nitric oxide in BV2, murine microglial cells. J. Neurosci. Res. 2005, 81:38-44.
14. Nakamura Y., Si Q.S., Kataoka K. Lipopolysaccharide-induced microglial activation in culture: temporal profiles of morphological change and release of cytokines and nitric oxide. Neurosci. Res. 1999, 35:95-100.
15. Bos J.L. Epac: a new cAMP target and new avenues in cAMP research. Nat. Rev. Mol. Cell Biol. 2003, 4:733-738.
16. de Rooij J., Rehmann H., van Triest M., Cool R.H., Wittinghofer A., Bos J.L. Mechanism of regulation of the Epac family of cAMP-dependent RapGEFs. J. Biol. Chem. 2000, 275:20829-20836.
17. de Rooij J., Zwartkruis F.J., Verheijen M.H., Cool R.H., Nijman S.M., Wittinghofer A., Bos J.L. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 1998, 396:474-477.
18. Enserink J.M., Christensen A.E., de Rooij J., van Triest M., Schwede F., Genieser H.G., Doskeland S.O., Blank J.L., Bos J.L. A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat. Cell Biol. 2002, 4:901-906.
19. Cawley S., Bekiranov S., Ng H.H., Kapranov P., Sekinger E.A., Kampa D., Piccolboni A., Sementchenko V., Cheng J., Williams A.J., Wheeler R., Wong B., Drenkow J., Yamanaka M., Patel S., Brubaker S., Tammana H., Helt G., Struhl K., Gingeras T.R. Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 2004, 116:499-509.
20. Spencer V.A., Sun J.M., Li L., Davie J.R. Chromatin immunoprecipitation: a tool for studying histone acetylation and transcription factor binding. Methods 2003, 31:67-75.
21. Sands W.A., Palmer T.M. Adenosine receptors and the control of endothelial cell function in inflammatory disease. Immunol. Lett. 2005, 101:1-11.
22. Sands W.A., Palmer T.M. Regulating gene transcription in response to cyclic AMP elevation. Cell. Signal. 2008, 20:460-466.
23. Tiwari S., Felekkis K., Moon E.Y., Flies A., Sherr D.H., Lerner A. Among circulating hematopoietic cells, B-CLL uniquely expresses functional EPAC1, but EPAC1-mediated Rap1 activation does not account for PDE4 inhibitor-induced apoptosis. Blood 2004, 103:2661-2667.
24. Smith F.D., Langeberg L.K., Cellurale C., Pawson T., Morrison D.K., Davis R.J., Scott J.D. AKAP-Lbc enhances cyclic AMP control of the ERK1/2 cascade. Nat. Cell Biol. 2010, 12:1242-1249.
25. Yao L., Fan P., Arolfo M., Jiang Z., Olive M.F., Zablocki J., Sun H.L., Chu N., Lee J., Kim H.Y., Leung K., Shryock J., Blackburn B., Diamond I. Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use-dependent inhibitor of dopamine synthesis. Nat. Med. 2010, 16:1024-1028.
26. Goodman R.H., Smolik S. CBP/p300 in cell growth, transformation, and development. Genes Dev. 2000, 14:1553-1577.
27. Janknecht R., Hunter T. Transcription. A growing coactivator network. Nature 1996, 383:22-23.
28. Janknecht R., Hunter T. Versatile molecular glue. Transcriptional control. Curr. Biol. 1996, 6:951-954.
29. Chrivia J.C., Kwok R.P., Lamb N., Hagiwara M., Montminy M.R., Goodman R.H. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 1993, 365:855-859.
30. Kwok R.P., Lundblad J.R., Chrivia J.C., Richards J.P., Bachinger H.P., Brennan R.G., Roberts S.G., Green M.R., Goodman R.H. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 1994, 370:223-226.
31. Moon E.Y., Pyo S. Lipopolysaccharide stimulates Epac1-mediated Rap1/NF-kappaB pathway in Raw 264.7 murine macrophages. Immunol. Lett. 2007, 110:121-125.
32. Leiro J., Garcia D., Arranz J.A., Delgado R., Sanmartin M.L., Orallo F. An Anacardiaceae preparation reduces the expression of inflammation-related genes in murine macrophages. Int. Immunopharmacol. 2004, 4:991-1003.
33. Marriott I., Bost K.L. Substance P diminishes lipopolysaccharide and interferon-gamma-induced TGF-beta 1 production by cultured murine macrophages. Cell. Immunol. 1998, 183:113-120.
34. Xiao B.G., Bai X.F., Zhang G.X., Hojeberg B., Link H. Shift from anti- to proinflammatory cytokine profiles in microglia through LPS- or IFN-gamma-mediated pathways. Neuroreport 1996, 7:1893-1898.
35. Kim H.S., Moon E.Y. Reactive oxygen species-induced expression of b cell activating factor (BAFF) is independent of toll-like receptor 4 and myeloid differentiation primary response gene 88. Biomol. Ther. 2009, 17:144-150.
36. Ster J., De Bock F., Guerineau N.C., Janossy A., Barrere-Lemaire S., Bos J.L., Bockaert J., Fagni L. Exchange protein activated by cAMP (Epac) mediates cAMP activation of p38 MAPK and modulation of Ca2+-dependent K+ channels in cerebellar neurons. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:2519-2524.
37. Kang G., Joseph J.W., Chepurny O.G., Monaco M., Wheeler M.B., Bos J.L., Schwede F., Genieser H.G., Holz G.G. Epac-selective cAMP analog 8-pCPT-2'-O-Me-cAMP as a stimulus for Ca2+-induced Ca2+ release and exocytosis in pancreatic beta-cells. J. Biol. Chem. 2003, 278:8279-8285.